- Report
- April 2022
- 217 Pages
Global
From €4113EUR$4,450USD£3,429GBP
- Report
- October 2025
- 188 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- October 2025
- 163 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- May 2025
- 138 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- August 2025
- 88 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- November 2025
- 96 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- November 2025
- 87 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- March 2025
- 93 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- January 2025
- 93 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- November 2022
- 342 Pages
Global
From €3328EUR$3,600USD£2,774GBP
- Report
- October 2022
- 171 Pages
Global
From €3328EUR$3,600USD£2,774GBP
- Report
- April 2026
- 150 Pages
Australia
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Brazil
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Canada
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Germany
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
India
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Indonesia
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Italy
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Japan
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2026
- 150 Pages
Malaysia
From €4483EUR$4,850USD£3,737GBP

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more